318 related articles for article (PubMed ID: 33022344)
21. Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA.
Li T; Lv M; Chen X; Yu Y; Zang G; Tang Z
Drug Des Devel Ther; 2019; 13():1289-1300. PubMed ID: 31118568
[No Abstract] [Full Text] [Related]
22. Bioactive components and mechanisms of poplar propolis in inhibiting proliferation of human hepatocellular carcinoma HepG2 cells.
Liu H; Li J; Yuan W; Hao S; Wang M; Wang F; Xuan H
Biomed Pharmacother; 2021 Dec; 144():112364. PubMed ID: 34700230
[TBL] [Abstract][Full Text] [Related]
23. Anticancer effects of bufalin on human hepatocellular carcinoma HepG2 cells: roles of apoptosis and autophagy.
Miao Q; Bi LL; Li X; Miao S; Zhang J; Zhang S; Yang Q; Xie YH; Zhang J; Wang SW
Int J Mol Sci; 2013 Jan; 14(1):1370-82. PubMed ID: 23344047
[TBL] [Abstract][Full Text] [Related]
24. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.
Ding J; Wen W; Xiang D; Yin P; Liu Y; Liu C; He G; Cheng Z; Yin J; Sheng C; Zhang W; Nan F; Ye W; Zhang X; Wang H
Oncotarget; 2015 May; 6(13):11627-39. PubMed ID: 25890498
[TBL] [Abstract][Full Text] [Related]
25. Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma.
Zhou Q; Lui VW; Lau CP; Cheng SH; Ng MH; Cai Y; Chan SL; Yeo W
Biochem Pharmacol; 2012 May; 83(9):1146-58. PubMed ID: 22285225
[TBL] [Abstract][Full Text] [Related]
26. NO donor inhibits proliferation and induces apoptosis by targeting PI3K/AKT/mTOR and MEK/ERK pathways in hepatocellular carcinoma cells.
Liu L; Chen J; Cao M; Wang J; Wang S
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1303-1314. PubMed ID: 31555866
[TBL] [Abstract][Full Text] [Related]
27. VI-16, a newly synthesized flavonoid, induces apoptosis through the mitochondrial pathway in human hepatoma cells.
Lu N; Wei L; Gong D; Gao Y; Dai Q; Li Z; Guo Q
Oncol Rep; 2012 Mar; 27(3):873-9. PubMed ID: 22179765
[TBL] [Abstract][Full Text] [Related]
28. Natural plant extract tubeimoside I promotes apoptosis-mediated cell death in cultured human hepatoma (HepG2) cells.
Wang Y; Deng L; Zhong H; Wang Y; Jiang X; Chen J
Biol Pharm Bull; 2011; 34(6):831-8. PubMed ID: 21628880
[TBL] [Abstract][Full Text] [Related]
29. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
[TBL] [Abstract][Full Text] [Related]
30. Fuzheng Qingjie Granules Inhibit Growth of Hepatoma Cells via Inducing Mitochondria-Mediated Apoptosis and Enhancing Immune Function.
Chen X; Cao Z; Zhang Y; Li J; Wang S; Du J; Liao L
Integr Cancer Ther; 2017 Sep; 16(3):329-338. PubMed ID: 27335087
[TBL] [Abstract][Full Text] [Related]
31. Suppression of AKT anti-apoptotic signaling by a novel drug candidate results in growth arrest and apoptosis of hepatocellular carcinoma cells.
Cuconati A; Mills C; Goddard C; Zhang X; Yu W; Guo H; Xu X; Block TM
PLoS One; 2013; 8(1):e54595. PubMed ID: 23355882
[TBL] [Abstract][Full Text] [Related]
32. A network pharmacology approach to investigate the anticancer mechanism of cinobufagin against hepatocellular carcinoma via downregulation of EGFR-CDK2 signaling.
Yang AL; Wu Q; Hu ZD; Wang SP; Tao YF; Wang AM; Sun YX; Li XL; Dai L; Zhang J
Toxicol Appl Pharmacol; 2021 Nov; 431():115739. PubMed ID: 34619160
[TBL] [Abstract][Full Text] [Related]
33. Anti-breast cancer and toxicity studies of total secondary saponin from Anemone raddeana Rhizome on MCF-7 cells via ROS generation and PI3K/AKT/mTOR inactivation.
Zhang D; Zhang Q; Zheng Y; Lu J
J Ethnopharmacol; 2020 Sep; 259():112984. PubMed ID: 32446927
[TBL] [Abstract][Full Text] [Related]
34. Arenobufagin Induces Apoptotic Cell Death in Human Non-Small-Cell Lung Cancer Cells via the Noxa-Related Pathway.
Ma L; Zhu Y; Fang S; Long H; Liu X; Liu Z
Molecules; 2017 Sep; 22(9):. PubMed ID: 28892004
[TBL] [Abstract][Full Text] [Related]
35. Identification of mTOR as a primary resistance factor of the IAP antagonist AT406 in hepatocellular carcinoma cells.
Zhen MC; Wang FQ; Wu SF; Zhao YL; Liu PG; Yin ZY
Oncotarget; 2017 Feb; 8(6):9466-9475. PubMed ID: 28036295
[TBL] [Abstract][Full Text] [Related]
36. A polysaccharide from pumpkin induces apoptosis of HepG2 cells by activation of mitochondrial pathway.
Shen W; Guan Y; Wang J; Hu Y; Tan Q; Song X; Jin Y; Liu Y; Zhang Y
Tumour Biol; 2016 Apr; 37(4):5239-45. PubMed ID: 26555544
[TBL] [Abstract][Full Text] [Related]
37. Jiedu Xiaozheng Yin decoction inhibits hepatoma cell proliferation by inducing apoptosis via the mitochondrial-mediated pathway.
Cao Z; Chen X; Lin W; Zhao J; Zheng L; Ye H; Liao L; Du J
Mol Med Rep; 2015 Aug; 12(2):2800-6. PubMed ID: 25936398
[TBL] [Abstract][Full Text] [Related]
38. ZL11n is a novel nitric oxide-releasing derivative of farnesylthiosalicylic acid that induces apoptosis in human hepatoma HepG2 cells via MAPK/mitochondrial pathways.
Yang L; Ling Y; Zhang Z; Zhao Q; Tang J; Ji H; Zhang Y
Biochem Biophys Res Commun; 2011 Jun; 409(4):752-7. PubMed ID: 21621522
[TBL] [Abstract][Full Text] [Related]
39. Shikonin inhibits the proliferation and induces the apoptosis of human HepG2 cells.
Yingkun N; Lvsong Z; Huimin Y
Can J Physiol Pharmacol; 2010 Dec; 88(12):1138-46. PubMed ID: 21164560
[TBL] [Abstract][Full Text] [Related]
40. CXC195 induces apoptosis and endoplastic reticulum stress in human hepatocellular carcinoma cells by inhibiting the PI3K/Akt/mTOR signaling pathway.
Chen XL; Fu JP; Shi J; Wan P; Cao H; Tang ZM
Mol Med Rep; 2015 Dec; 12(6):8229-36. PubMed ID: 26496900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
